Recent News for UBX - Unity Biotechnology, Inc.

Date Title
Dec 2 VRAY, TRVG, UBX and PB among after hours movers
Nov 12 The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat
Nov 10 The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict
Nov 6 Unity Biotechnology reports Q3 results
Nov 6 UNITY Biotechnology, Inc. Reports Third Quarter 2019 Financial Results and Business Updates
Oct 31 Unity Biotechnology, Inc. (UBX) Is Burning These Hedge Funds
Oct 31 UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee
Oct 24 UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting
Oct 23 We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate
Oct 23 Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results
Sep 20 UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference
Sep 13 Unity Biotechnology (UBX) Investor Presentation - Slideshow
Aug 27 UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences
Aug 23 Did You Manage To Avoid Unity Biotechnology's (NASDAQ:UBX) Painful 66% Share Price Drop?
Aug 22 Unity Biotech: Buy at the Low?
Aug 16 The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission
Aug 7 Unity Biotechnology EPS misses by $0.07
Aug 7 UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates
Aug 7 The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Jul 30 UNITY Biotechnology, Inc. Announces Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee
Jul 30 UNITY Biotechnology, Inc. To Announce Second Quarter 2019 Financial Results
Jul 26 Stocks That Managed to Breach 52-Week Lows Friday
Jun 18 Here's Why Unity Biotechnology Dropped as Much as 20.4% Today
Jun 18 Intrexon and Enlivex Therapeutics among healthcare gainers; ContraVir Pharmaceuticals leads the losers
Jun 18 Unity Bio reports promising UBX0101 data

Back to the Main UBX Page...